A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
Public ClinicalTrials.gov record NCT00667342. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study of Bevacizumab, a Humanized Monoclonal Antibody Against Vascular Endothelial Growth Factor (VEGF), in Combination With Chemotherapy for Treatment of Osteosarcoma
Study identification
- NCT ID
- NCT00667342
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Enrollment
- 43 participants
Conditions and interventions
Interventions
- Bevacizumab Biological
- Cisplatin Drug
- Doxorubicin Drug
- Ifosfamide Drug
- Methotrexate Drug
- Radiotherapy Radiation
- Surgery Procedure
- etoposide Drug
Biological · Drug · Radiation + 1 more
Eligibility (public fields only)
- Age range
- Up to 30 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2, 2008
- Primary completion
- Jul 31, 2014
- Completion
- Jul 31, 2017
- Last update posted
- Aug 6, 2023
2008 – 2017
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rady Children's Hospital and Health Center | San Diego | California | 92123 | — |
| Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21231 | — |
| NCI/NIH - Pediatric Oncology Branch | Bethesda | Maryland | 20892 | — |
| St Jude Children's Research Hospital | Memphis | Tennessee | 38105 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00667342, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2023 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00667342 live on ClinicalTrials.gov.